Back
Kingsway Financial Services 10K Form
Buy
54
KFS
Kingsway Financial Services
Last Price:
8.98
Seasonality Move:
2.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-07 | 10Q | KFS/Kingsway Financial Services Quarterly |
| 2023-08-08 | 10Q | KFS/Kingsway Financial Services Quarterly |
| 2023-05-09 | 10Q | KFS/Kingsway Financial Services Quarterly |
| 2022-11-10 | 10Q | KFS/Kingsway Financial Services Quarterly |
| 2022-08-04 | 10Q | KFS/Kingsway Financial Services Quarterly |
| 2022-05-06 | 10Q | KFS/Kingsway Financial Services Quarterly |
Receive KFS News And Ratings
See the #1 stock for the next 7 days that we like better than KFS
KFS Financial Statistics
Sales & Book Value
| Annual Sales: | $107.66M |
|---|---|
| Cash Flow: | $218K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.37 |
| Price / Book: | 25 |
Profitability
| EPS (TTM): | -0.36000 |
|---|---|
| Net Income (TTM): | $-9.47M |
| Gross Margin: | -- |
| Return on Equity: | -42.93% |
| Return on Assets: | -4.84% |
Kingsway Financial Services Earnings Forecast
Key Kingsway Financial Services Financial Ratios
- The Interest Expense is 26.53% of Operating Income.
- The Net Earning history of KFS is 21.88% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 18 years.
Kingsway Financial Services Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Insurance |
| Sector: | Financials |
| Current Symbol: | KFS |
| CUSIP: | 496904 |
| Website: | kingsway-financial.com |
Debt
| Debt-to-Equity Ratio: | 3.21 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 10.12 |
|---|---|
| Forward P/E Ratio: | 0 |
KFS Technical Analysis vs Fundamental Analysis
Buy
54
Kingsway Financial Services (KFS)
is a Buy
Is Kingsway Financial Services a Buy or a Sell?
-
Kingsway Financial Services stock is rated a Buy
The current Kingsway Financial Services [KFS] share price is $9.01. The Score for KFS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.